MINI FUTURE LONG - ZEALAND PHARMA Share Price

DE000MB26CB7

Market Closed - Börse Stuttgart 19:23:31 03/07/2024 BST
9.19 ^EUR	+0.66%

Current month	-0.97%
1 month	+52.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ZEALAND PHARMA A/S

Latest news about ZEALAND PHARMA A/S

Zealand Pharma major shareholder announcement: Van Herk Investments	06-28	GL
Would you like some more inflation?	06-28
Zealand Pharma completes registration of capital increase	06-28	GL
Zealand Pharma Upsizes Directed Share Offering to $1 Billion Amid Strong Demand	06-26	MT

More news

Quotes 5-day view

Date	Price	Change
03/07/24	9.19	+0.66%
02/07/24	9.13	-5.88%
01/07/24	9.7	+4.53%
28/06/24	9.28	+3.92%
27/06/24	8.93	-1.33%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 07:23 pm

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	ZEALAND PHARMA A/S
Issuer	Morgan Stanley
WKN	MB26CB
ISIN	DE000MB26CB7
Date issued	10/01/2023
Strike	199.6 kr
Maturity	Unlimited
Parity	10 : 1
Emission price	0.47 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	9.7 €
Lowest since issue	0.3 €

Company Profile

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Sector

More about the company

Ratings for Zealand Pharma A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Zealand Pharma A/S

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

890 DKK

Average target price

918 DKK

Spread / Average Target

+3.15%

Consensus